Amended Quarterly Report (10-q/a)

0001081834 true --12-31 Q2 2022 100000000 100000000 4043966 0001081834 2022-01-01 2022-06-30 0001081834 2022-08-22 0001081834 2022-06-30 0001081834 2021-12-31 0001081834 us-gaap:SeriesAPreferredStockMember 2022-06-30 0001081834 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001081834 us-gaap:SeriesBPreferredStockMember 2022-06-30 0001081834 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001081834 2022-04-01 2022-06-30 0001081834 2021-04-01 2021-06-30 0001081834 2021-01-01 2021-06-30 0001081834 uoli:SeriesAAndBPreferredStockMember 2021-12-31 0001081834 us-gaap:PreferredStockMember 2021-12-31 0001081834 us-gaap:CommonStockMember 2021-12-31 0001081834 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001081834 us-gaap:RetainedEarningsMember 2021-12-31 0001081834 uoli:SeriesAAndBPreferredStockMember 2022-03-31 0001081834 us-gaap:PreferredStockMember 2022-03-31 0001081834 us-gaap:CommonStockMember 2022-03-31 0001081834 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001081834 us-gaap:RetainedEarningsMember 2022-03-31 0001081834 2022-03-31 0001081834 uoli:SeriesAAndBPreferredStockMember 2020-12-31 0001081834 us-gaap:PreferredStockMember 2020-12-31 0001081834 us-gaap:CommonStockMember 2020-12-31 0001081834 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001081834 us-gaap:RetainedEarningsMember 2020-12-31 0001081834 2020-12-31 0001081834 uoli:SeriesAAndBPreferredStockMember 2021-03-31 0001081834 us-gaap:PreferredStockMember 2021-03-31 0001081834 us-gaap:CommonStockMember 2021-03-31 0001081834 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001081834 us-gaap:RetainedEarningsMember 2021-03-31 0001081834 2021-03-31 0001081834 uoli:SeriesAAndBPreferredStockMember 2022-01-01 2022-03-31 0001081834 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001081834 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001081834 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001081834 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001081834 2022-01-01 2022-03-31 0001081834 uoli:SeriesAAndBPreferredStockMember 2022-04-01 2022-06-30 0001081834 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001081834 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001081834 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001081834 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001081834 uoli:SeriesAAndBPreferredStockMember 2021-01-01 2021-03-31 0001081834 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001081834 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001081834 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001081834 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001081834 2021-01-01 2021-03-31 0001081834 uoli:SeriesAAndBPreferredStockMember 2021-04-01 2021-06-30 0001081834 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001081834 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001081834 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001081834 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001081834 uoli:SeriesAAndBPreferredStockMember 2022-06-30 0001081834 us-gaap:PreferredStockMember 2022-06-30 0001081834 us-gaap:CommonStockMember 2022-06-30 0001081834 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001081834 us-gaap:RetainedEarningsMember 2022-06-30 0001081834 uoli:SeriesAAndBPreferredStockMember 2021-06-30 0001081834 us-gaap:PreferredStockMember 2021-06-30 0001081834 us-gaap:CommonStockMember 2021-06-30 0001081834 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001081834 us-gaap:RetainedEarningsMember 2021-06-30 0001081834 2021-06-30 0001081834 2021-05-13 2021-05-14 0001081834 us-gaap:CommonStockMember uoli:RaymondFuMember 2022-06-19 2022-06-21 0001081834 us-gaap:CommonStockMember uoli:RaymondFuMember 2022-06-21 0001081834 uoli:DefinitiveShareAgreementMember uoli:AsiaImageInvestmentLimitedMember srt:PresidentMember 2020-03-01 2020-03-02 0001081834 2020-03-01 2020-03-02 0001081834 uoli:UonliveHongKongLimitedMember us-gaap:SeriesBPreferredStockMember 2020-05-25 2020-05-26 0001081834 uoli:UonliveHongKongLimitedMember us-gaap:SeriesAPreferredStockMember 2020-05-25 2020-05-26 0001081834 uoli:ChiefExecutiveOfficerAndPresidentMember 2022-06-30 0001081834 uoli:ChiefExecutiveOfficerAndPresidentMember 2021-12-31 0001081834 us-gaap:CommonStockMember 2020-03-03 2020-03-04 0001081834 us-gaap:SeriesBPreferredStockMember 2020-06-07 2020-06-08 0001081834 us-gaap:SeriesBPreferredStockMember 2020-06-08 0001081834 2021-05-27 2021-05-28 0001081834 us-gaap:CommonStockMember uoli:RaymondFuMember 2022-06-30 0001081834 us-gaap:CommonStockMember uoli:RaymondFuMember 2021-12-31 0001081834 us-gaap:SeriesBPreferredStockMember 2018-01-01 0001081834 us-gaap:SeriesBPreferredStockMember uoli:ChuangFuQuKuaiLianTechnologyShenzhenLimitedMember 2018-09-06 2018-09-07 0001081834 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-06-30 0001081834 us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-06-30 0001081834 us-gaap:ConvertibleCommonStockMember 2022-06-30 0001081834 us-gaap:SeriesAPreferredStockMember srt:DirectorMember 2020-10-07 0001081834 us-gaap:SeriesAPreferredStockMember uoli:UonliveHongKongLimitedMember 2020-10-06 2020-10-07 0001081834 us-gaap:SeriesAPreferredStockMember uoli:UonliveHongKongLimitedMember 2020-10-06 2020-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q/A

(Amendment No. 1)

x Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2022

¨ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Commission file number 000-26119

UONLIVE CORPORATION.

(Exact name of small business issuer as specified in its charter)

Nevada

4832

87-0629754

State or other jurisdiction

of incorporation or organization

Primary Standard Industrial

Classification Number

IRS Employer

Identification Number

1107, Lippo Centre Tower 1, 89 Queensway, Admiralty, Hong Kong

Tel: +1 (852) 3703-6155

(Address and telephone number of principal executive offices)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer	¨	Non-accelerated filer	x
Large accelerated filer	¨	Smaller reporting company	x
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Securities registered pursuant to Section 12(b) of the Act: None

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: 132,606,582 common shares issued and outstanding as of August 22, 2022.

EXPLANATORY NOTE

Uonlive Corporation (the “Company”) hereby amends its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, filed with the Securities and Exchange Commission (the “SEC”) on August 22, 2022 (the “Original Quarterly Report”), as set forth in this Amendment No. 1 on Form 10-Q/A (the “Form 10-Q/A” or “Amended Quarterly Report”), to restate its financial statements and related disclosures as of and for the quarter ended June 30, 2022.

This Amendment is filed to include the XBRL Interactive Data File presentation and exhibits not included in the Original Filing.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain information included in this Quarterly Report on Form 10-Q and other filings of the Registrant under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as well as information communicated orally or in writing between the dates of such filings, contains or may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Forward-looking statements in this Quarterly Report on Form 10-Q, including without limitation, statements related to our plans, strategies, objectives, expectations, intentions and adequacy of resources, are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, trends and uncertainties that could cause actual results to differ materially from expected results. Among these risks, trends and uncertainties are the availability of working capital to fund our operations, the competitive market in which we operate, the efficient and uninterrupted operation of our computer and communications systems, our ability to generate a profit and execute our business plan, the retention of key personnel, our ability to protect and defend our intellectual property, the effects of governmental regulation, and other risks identified in the Registrant’s filings with the Securities and Exchange Commission from time to time.

In some cases, forward-looking statements can be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms or other comparable terminology. Although the Registrant believes that the expectations reflected in the forward-looking statements contained herein are reasonable, the Registrant cannot guarantee future results, levels of activity, performance or achievements. Moreover, neither the Registrant, nor any other person, assumes responsibility for the accuracy and completeness of such statements. The Registrant is under no duty to update any of the forward-looking statements contained herein after the date of this Quarterly Report on Form 10-Q.

UONLIVE CORPORATION

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

		Page
PART I FINANCIAL INFORMATION:

Item 1.	Consolidated Financial Statements (Unaudited)	4
	Consolidated Balance Sheets as of June 30, 2022 (Unaudited) and December 31, 2021	5
	Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2022 (Unaudited) and June 30, 2021 (unaudited)	6
	Consolidated Statements of Changes in Stockholders’ Deficit for the Six Months Ended June 30, 2022 and June 30, 2021 (unaudited)	7
	Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2022 and June 30, 2021 (unaudited)	9
	Notes to the Unaudited Consolidated Financial Statements	10

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	18

PART II OTHER INFORMATION:

Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3.	Defaults Upon Senior Securities	20
Item 4.	Submission of Matters to a Vote of Securities Holders	20
Item 5.	Other Information	20
Item 6.	Exhibits	21
	Signatures	22

PART 1 – FINANCIAL INFORMATION

Item 1. Financial Statements

The accompanying interim consolidated financial statements of UONLIVE CORPORATION. (“the Company”, “we”, “us” or “our”), have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted principles have been condensed or omitted pursuant to such rules and regulations.

The interim consolidated financial statements should be read in conjunction with the company’s latest annual financial statements.

In the opinion of management, the consolidated financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

UONLIVE CORPORATION.

CONSOLIDATED BALANCE SHEETS

(Unaudited)

	June 30, 2022			December 31, 2021
ASSETS
CURRENT ASSETS:
Cash	$	64,289		$	52,279
Advances to suppliers		1,080,800			-
Prepaid expenses and other assets		-			3,806
Loan to related party		27,216			-
Total current assets		1,172,305			56,085

Fixed assets, net of accumulated depreciation		853			1,065
TOTAL ASSETS	$	1,173,158		$	57,150

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:
Accounts payable and accrued expenses		176,265			14,408
Loan payable – related party		-			170,712
Notes payable – related party		57,938			167,554
Contract liability		822,040			50,000
Total current liabilities		1,056,243			402,674


Commitments and Contingencies		-			-

STOCKHOLDERS’ EQUITY
Series A Convertible Preferred stock, par value $0.001 per share; 2,000,000 shares authorized; 520,000 shares issued and outstanding at June 30, 2022 and December 31, 2021		520			520
Series B Convertible Preferred stock, par value $0.001 per share; 1,000,000 shares authorized; 150,000 shares issued and outstanding at June 30, 2022 and December 31, 2021		150			150
Preferred stock, par value $0.001 per share; 10,000,0000 shares authorized; 500,000 shares issued and outstanding at June 30, 2022 and December 31, 2021		500			500
Common stock, par value $0.001 per share; 1,000,000,000 shares authorized; 132,606,582 and 32,606,582 shares issued and outstanding at June 30, 2022 and December 31, 2021		132,607			32,607
Additional Paid in Capital		3,924,665			3,664,665
Accumulated Deficit		(3,941,527	)		(4,043,966	)
Total stockholder’s equity (deficit)		116,915			(345,524	)

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,173,158		$	57,150

The accompanying notes are an integral part of these consolidated financial statements.

UONLIVE CORPORATION.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


	For the three months ended						For the six months ended
	June 30,						June 30,
	2022			2021			2022			2021
Sales		720,002			-			875,002			-
Cost of sales		(601,000	)		-			(725,000	)		-
Gross Profit		119,002			-			150,002			-

Operating expenses
General and administrative expenses		2,748			4,413			5,455			11,627
Professional fees		11,850			27,500			42,107			46,800
Total operating expense		14,598			31,913			47,562			58,427

Income (Loss) from operations		104,404			(31,913	)		102,439			(58,427	)

Other income (expense)
		-			-			-			-
Total other income		-			-			-			-

Net income (loss)	$	104,404		$	(31,913	)	$	102,439		$	(58,427	)
Net income (loss) per common share – basic and diluted	$	0.00		$	(0.00	)	$	0.00		$	(0.00	)
Weighted average common shares outstanding – basic and diluted		38,101,087			32,606,582			38,101,087			32,606,582

The accompanying notes are an integral part of these consolidated financial statements.

UONLIVE CORPORATION.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND JUNE 30, 2021

(Unaudited)

																		Total
	Series A and B Preferred Stock				Preferred Stock				*Common Stock				Additional		Accumulated			Stockholders'

	Number of Shares		Par Value		Number of Shares		Par Value		Number of Shares		Par Value		Paid in Capital		Deficit			Deficit

Balance - December 31, 2021		670,000		670		500,000		500		32,606,582		32,607		3,664,665		(4,043,966	)		(345,524	)



Net Loss		-		-		-		-		-		-		-		(1,964	)		(1,964	)
Balance – March 31, 2022		670,000	$	670		500,000	$	500		32,606,582	$	32,607	$	3,664,665	$	(4,045,931	)	$	(347,489	)


Forgiveness of related part debt						-				100,000,000		100,000		260,000					360,000
Net income		-		-		-										104,404			104,404
Balance – June 30, 2022		670,000	$	670		500,000	$	500		132,606,582	$	132,607	$	3,924,665	$	(3,941,527	)	$	116,915

·	Balances have been retroactively adjusted to reflect 1 for 20 reverse stock spilt

The accompanying notes are an integral part of these consolidated financial statements.

UONLIVE CORPORATION.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND JUNE 30, 2021

(Unaudited)

																			Total
	Series A and B Preferred Stock				Preferred Stock				Common Stock				Capital			Accumulated			Stockholders'
	Number of Shares		Par Value		Number of Shares		Par Value		Number of Shares		Par Value		Deficiency			Deficit			Deficit


Balance - December 31, 2020		670,000		670		500,000		500		652,096,355		652,096		(475,243	)		(441,735	)		(263,712	)





Net loss		-		-		-		-		-		-		-			(26,514	)		(26,514	)
Balance – March 31, 2021		670,000	$	670		500,000	$	500		652,096,355	$	652,096	$	(475,243	)	$	(468,249	)	$	(290,226	)



Net loss		-		-		-		-		-		-		-			(31,913	)		(31,913	)
Balance – June 30, 2021		670,000	$	670		500,000	$	500		652,096,355	$	652,096	$	(475,243	)	$	(500,162	)	$	(322,139	)

The accompanying notes are an integral part of these consolidated financial statements.

UONLIVE CORPORATION.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE PERIOD

(Unaudited)


	For the Six Months Ended June 30,
	2022			2021
OPERATING ACTIVITIES:

Net Income (Loss)	$	102,439		$	(58,427	)
Adjustments to reconcile net loss to net cash (used in) operating activities:

Depreciation expense		212			-

Changes in assets and liabilities
Prepaid expense		3,806			(3,000	)
Advances to suppliers		(1,080,800	)		-
Accounts payable and accrued expenses		161,857			-
Loan payable – related party		79,672			62,715
Contract liability		772,040			-
NET CASH PROVIDED BY OPERATING ACTIVITIES		39,226			1,288

Cash paid for fixed assets		-			(1,288	)
Loan to related party		(27,216	)		-
NET CASH USED IN INVESTING ACTIVITIES		(27,216	)		(1,288	)

NET CHANGE IN CASH		12,010			-

CASH – BEGINNING OF PERIOD		52,279			2,758
CASH – END OF PERIOD	$	64,289		$	2,758

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:

Cash paid during the periods for:
Interest		-			-
Taxes		-			-

Non-cash investing and financing activities:
Forgiveness of related party debt		(360,000	)		-

The accompanying notes are an integral part of these consolidated financial statements.

UONLIVE CORPORATION.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND DECEMBER 31, 2021

(Unaudited)

Note 1 – Organization and basis of accounting

Principles of Consolidation

The Company prepares its consolidated financial statements on the accrual basis of accounting. The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiary. All intercompany accounts, balances and transactions have been eliminated in the consolidation.

Basis of Presentation and Organization

This summary of significant accounting policies of UONLIVE CORPORATION. (a development stage company) (“the Company”) is presented to assist in understanding the Company's consolidated financial statements. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the accompanying consolidated financial statements. The Company has realized minimal revenues from its planned principal business purpose and, accordingly, is considered to be in its development stage in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic No. 915 (SFAS No. 7). The Company has elected a fiscal year end of December 31.

Business Description

Uonlive Corporation (“UOLI” or the “Company”) was incorporated under the laws of the State of Nevada on January 29, 1998 as Weston International Development Corporation. On July 28, 1998, its name was changed to Txon International Development Corporation. On September 15, 2000, the Company changed its name to China World Trade Corporation. On July 2, 2008, the Company further changed its name to Uonlive Corporation.

The Company ceased operations in early 2015. The Company has fully impaired all assets since the shutdown of its operations in 2015 and has recorded the effects of this impairment as part of its discontinued operations.

On June 15, 2018, the eight judicial District Court of Nevada appointed Small Cap Compliance, LLC as custodian for Uonlive Corporations., proper notice having been given to the officers and directors of Uonlive Corporation. There was no opposition.

On September 10, 2019, the Company filed a certificate of revival with the state of Nevada, appointing Raymond Fu as, President, Secretary, Treasurer and Director.

On May 14^th, 2021, the Company approved a 1 for 20 reverse stock split.

On June 21, 2022, the Company issued 100,000,000 shares of common stock valued at $0.0036 per share to Raymond Fu as repayment of a portion of all related party debt totaling $360,000.

Reorganization and Share Exchange

On March 02, 2020, the Company entered into a Definitive Share Agreement whereby Raymond Fu, the sole shareholder of Asia Image Investment Limited (“Asia Image”), relinquished all his shares in Asia Image and acquired 100,000 shares of the Company. Consequently, Asia Image became a wholly-owned subsidiary of the Company.

Since the major shareholder of Uonlive retained control of both the Company and Asia Image, the share exchange was accounted for as a reverse merger. As such, the Company recognized the assets and liabilities of Asia Image, acquired in the Reorganization, at their historical carrying amounts.

The accompanying financial statements are prepared on the basis of accounting principles generally accepted in the United States of America (“GAAP”). The Company is a development stage enterprise devoting substantial efforts to establishing a new business, financial planning, raising capital, and research into products which may become part of the Company’s product portfolio. The Company has not realized significant sales through since inception. A development stage company is defined as one in which all efforts are devoted substantially to establishing a new business and, even if planned principal operations have commenced, revenues are insignificant.

The accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital, or be successful in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Note 2 – Summary of significant accounting policies

Cash and Cash Equivalents

For purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.

Employee Stock-Based Compensation

The Company accounts for stock-based compensation in accordance with ASC 718 Compensation - Stock Compensation (“ASC 718”). ASC 718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based on the estimated number of awards that are expected to vest and will result in a charge to operations.

Use of Estimates

The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Management makes its best estimate of the outcome for these items based on information available when the financial statements are prepared. Actual results could differ from those estimates.

Subsequent Event

The Company evaluated subsequent events through the date when financial statements are issued for disclosure consideration.

Recent Accounting Pronouncements

On December 18, 2019, the FASB issued ASU 2019-12, which modifies ASC 740 to simplify the accounting for income taxes. The ASU’s amendments are based on changes that were suggested by stakeholders as part of the FASB’s simplification initiative (i.e., the Board’s effort to reduce the complexity of accounting standards while maintaining or enhancing the helpfulness of information provided to financial statement users. This ASU was adopted by the Company on September 1, 2021. The Company evaluated and concluded that the adoption did not have a material impact on the Company’s financial position, results of operations or cash flows.

In May 2021, the FASB issued ASU 2021-04 in response EITF consensus. This ASU addresses how the issuer should account for modifications or exchanges of Freestanding Equity Classified Written Call Options. Freestanding written call options (such as warrants) are sometimes issued to enhance the marketability of a company’s debt or common stock offering. Some of these warrants are classified as equity in the issuer’s financial statements but are not accounted for as either stock compensation or derivatives. US GAAP does not address how the issuer should account for modifications of these instruments. The FASB has approved an EITF consensus to fill that void. Under the new guidance, if the modification does not change the instrument’s classification as equity, the company that issued the warrants accounts for the modification as an exchange of the original instrument for a new instrument. In general, if the fair value of the ‘new’ instrument is greater than the fair value of the ‘original’ instrument, the excess is recognized based on the substance of the transaction, as if the issuer had paid cash. The new rule is effective for fiscal years beginning after December 15, 2021 for both public and private companies. Transition is prospective. Early adoption is permitted, as discussed further below. The Company is evaluating whether this will have any impact of on its consolidated financial statements.

Other recent accounting pronouncements issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or in management’s opinion will not have a material impact on the Company’s present or future consolidated financial statements.

Note 3- Going Concern

In early January 2020, an outbreak of a respiratory illness caused by the coronavirus was identified in Wuhan, China. As part of its effort to combat the virus, the government of China has placed travel restrictions throughout parts of China. This has resulted in some of the Company’s customers and suppliers being closed for an extended period or operating at significantly below their normal capacity and will also affect our suppliers that source some of their materials from China. The duration and intensity of this global health emergency and related disruptions is uncertain. The duration of this crisis and its impact on both the Company’s customers and supply chain is expected to have a material impact on the consolidated results of operations, cash flows and financial condition, but cannot be reasonably estimated at this time.

The Company has an accumulated deficit of $3,941,527 and working capital of $116,062, as of June 30, 2022, and a accumulated deficit of $4,043,966 and a working capital deficit of $346,589 as of December 31, 2021. The accompanying consolidated financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital or be successful in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

Note 4 – Related party transactions

On May 26, 2020, the Company issued 650,000 shares of Series B Convertible Preferred Stock and 520,000 (series A convertible preferred stock to Uonlive (Hong Kong) Limited for the provision of management services valued at $54,586. Mr. Raymond Fu, President, and Chief Executive Officer of the Company is also the indirect beneficial owner of Uonlive (Hong Kong) Limited.

Loan Payable-Related Party

As of June 30, 2022 and December 31, 2021 the Company has a loan payable of $0 and $170,712 to Mr. Raymond Fu, President and Chief Executive Officer of the Company, respectively. This loan is unsecured, non-interest bearing and it is repayable on demand.

Note Payable-Related Party

As of June 30, 2022 and December 31, 2021 the Company has a note payable of $57,938 and $167,554 to Mr. Raymond Fu, President and Chief Executive Officer of the Company, respectively. This note is unsecured, non-interest bearing and it is repayable on demand.

Note 5 – Common stock

On March 04, 2020, the Company issued 100,000 shares of common stock to a shareholder for a total price of $100 as part of the share exchange and reverse merger.

On June 08, 2020, the Company converted 650,000 Series B convertible Preferred Stock into 650,000,000 common stock.

On May 28^th, 2021, the Company approved a 1 for 20 reverse stock split.

On June 21, 2022, the Company issued 100,000,000 shares of common stock valued at $0.0036 per share to Raymond Fu as repayment of a portion of all related party debt totaling $360,000.

As of June 30, 2022 and December 31, 2021, a total of 132,606,582 and 32,606,582 shares of common stock with par value $0.001 remain outstanding, respectively.

Note 6 – Preferred stock

Preferred Stock

On January 01, 2018, the Company created 1,000,000 shares of Series B Convertible Preferred Stock, out of the 1,000,000 shares that were already authorized. On September 07, 2018, the Company issued 150,000 shares of the Series B convertible preferred stock to Chuang Fu Qu Kuai Lian Technology (Shenzhen) Limited for services valued at $30,000.

On May 26, 2020, the Company issued 650,000 shares of Series B Convertible Preferred Stock to Uonlive (Hong Kong) Limited for the provision of management services valued at $44,479.

The following is a description of the material rights of our Series B Convertible Preferred Stock:

Each share of Series B convertible Preferred Stock shall have a par value of $0.001 per share. The Series B Preferred Stock shall vote on any matter that may from time to time be submitted to the Company’s shareholders for a vote, on a 1,000 for one basis. If the Company effects a stock split which either increases or decreases the number of shares of Common Stock outstanding and entitled to vote, the voting rights of the Series A shall not be subject to adjustment unless specifically authorized.

Each share of Series B Convertible Preferred Stock shall be convertible into 1,000 shares of Common Stock (“Conversion Ratio”), at the option of a Holder, at any time and from time to time, from and after the issuance of the Series C Preferred Stock.

In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary, subject to the rights of any existing series of Preferred Stock or to the rights of any series of Preferred Stock which may from time to time hereafter come into existence, the holders of the Series B Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of the Corporation to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the price per share actually paid to the Corporation upon the initial issuance of the Series B Preferred Stock (each, the “the Original Issue Price”) for each share of Series B Preferred Stock then held by them, plus declared but unpaid dividends. Unless the Corporation can establish a different Original Issue Price in connection with a particular sale of Series B Preferred Stock, the Original issue price shall be $0.001 per share for the Series B Preferred Stock. If, upon the occurrence of any liquidation, dissolution or winding up of the Corporation, the assets and funds thus distributed among the holders of the Series B Preferred Stock shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of any existing series of Preferred Stock or to the rights of any series of Preferred Stock which may from time to time hereafter come into existence, the entire assets and funds of the corporation legally available for distribution shall be distributed ratably among the holders of the each series of Preferred Stock in proportion to the preferential amount each such holder is otherwise entitled to receive.

The Series B Preferred Stock shares are nonredeemable other than upon the mutual agreement of the Company and the holder of shares to be redeemed, and even in such case only to the extent permitted by this Certificate of Designation, the Corporation’s Articles of Incorporation and applicable law.

Series B Preferred Stock shall be convertible, at the option of the holder thereof, at any time after the date of issuance of such share, at the office of the Corporation or any transfer agent for such stock, into such number of fully paid and nonassessable shares of Common Stock as is determined by dividing the Original Issue Price of the Series B Preferred Stock by the Series B Conversion Price applicable to such share, determined as hereafter provided, in effect on the date the certificate is surrendered for conversion.

On October 07, 2020, the Company’s board of directors approved the creation of 2,000,000 shares of a Series A Preferred stock. On that same dated the Company issued 520,000 shares of its newly created Series A Preferred Stock to Uonlive (Hong Kong) Limtied as payment for management services provided valued at $290,990.

As of June 30, 2022 and December 31, 2021, the Company has 150,000 shares of Series B Convertible preferred shares, 520,000 shares of Series A Convertible preferred shares and 500,000 shares of preferred stock outstanding

Note 7 – Subsequent Event

In accordance with ASC 855 the Company’s management reviewed all material events through the date these financial statements were available to be issued, there was only one material subsequent event.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward looking statement notice

Statements made in this Form 10-Q that are not historical or current facts are “forward-looking statements” made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 (the “Act”) and Section 21E of the Securities Exchange Act of 1934. These statements often can be identified by the use of terms such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “approximate” or “continue,” or the negative thereof. We intend that such forward-looking statements be subject to the safe harbors for such statements. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Any forward-looking statements represent management’s best judgment as to what may occur in the future. However, forward-looking statements are subject to risks, uncertainties and important factors beyond our control that could cause actual results and events to differ materially from historical results of operations and events and those presently anticipated or projected. We disclaim any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.

Financial information contained in this quarterly report and in our unaudited interim financial statements is stated in United States dollars and are prepared in accordance with United States generally accepted accounting principles.

In March 2020, the World Health Organization categorized Coronavirus Disease 2019 (“COVID-19”) as a pandemic, and the President of the United States declared the COVID-19 outbreak a national emergency. The services we provide are currently designated an essential critical infrastructure business under the President’s COVID-19 guidance, the continued operation of which is vital for national public health, safety and national economic security. The extent of the impact of the COVID-19 outbreak on our operational and financial performance will depend on certain developments, including the duration and spread of the outbreak, its impact on our customers and vendors, and the range of governmental and community reactions to the pandemic, which are uncertain and cannot be fully predicted at this time.

Management’s Plan of Operation

The following discussion contains forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use of words such as “anticipate”, “estimate”, “expect”, “project”, “intend”, “plan”, “believe”, and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. From time to time, we also may provide forward-looking statements in other materials we release to the public.

Overview

The Company’s current business objective is to seek a business combination with an operating company. We intend to use the Company’s limited personnel and financial resources in connection with such activities. The Company will utilize its capital stock, debt or a combination of capital stock and debt, in effecting a business combination. It may be expected that entering into a business combination will involve the issuance of restricted shares of capital stock. The issuance of additional shares of our capital stock:

●

may significantly reduce the equity interest of our stockholders;

●

will likely cause a change in control if a substantial number of our shares of capital stock are issued, and most likely will also result in the resignation or removal of our present officer and director; and

●

may adversely affect the prevailing market price for our common stock.

Similarly, if we issued debt securities, it could result in:

●

default and foreclosure on our assets if our operating revenues after a business combination were insufficient to pay our debt obligations;

●

acceleration of our obligations to repay the indebtedness even if we have made all principal and interest payments when due if the debt security contained covenants that required the maintenance of certain financial ratios or reserves and any such covenants were breached without a waiver or renegotiations of such covenants;

●

our immediate payment of all principal and accrued interest, if any, if the debt security was payable on demand; and

●

our inability to obtain additional financing, if necessary, if the debt security contained covenants restricting our ability to obtain additional financing while such security was outstanding.

Recent developments

In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. This pandemic has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. Due to the outbreak and spread of COVID-19, the Company’s management and advisors responsible for financial reporting have experienced administrative delays, include travel restrictions and reduced work hours. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no material adverse impacts on the Company’s results of operations and financial position at June 30, 2022. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of this Quarter Report on Form 10-Q. These estimates may change, as new events occur, and additional information is obtained.

Results of operations

The following comparative analysis on results of operations was based primarily on the comparative financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the financial statements and the notes to those statements that are included elsewhere in this report.

Results Of Operations During The Three Months Ended June 30, 2022 As Compared To The Three Months Ended June 30, 2021

Revenue

For the three months ended June 30, 2022 and three months ended June 30, 2021, the Company generated $720,002 of revenue and $0 revenue, respectively.

Cost of Revenue

For the three months ended June 30, 2022 and three months ended June 30, 2021, the Company incurred $601,000 of cost of revenue and $0 cost of revenue, respectively.

Expenses

For the three months ended June 30, 2022 and June 30, 2021, we incurred operating expenses of $14,598 and $31,913, respectively. The decrease in operating expenses is mainly due to a decrease in professional fees in June 2022 associated with accounting and audit fees.

Net Income (Loss)

For the three months ended June 30, 2022 and June 30, 2021, we incurred net income of $104,404 and a net loss of $31,913, respectively. The increase in net income during the three months ended is mainly due to increase in revenue during the three months ended June 2022.

Results Of Operations During The Six Months Ended June 30, 2022 As Compared To The Six Months Ended June 30, 2021

Revenue

For the six months ended June 30, 2022 and six months ended June 30, 2021, the Company generated $875,002 of revenue and $0 revenue, respectively.

Cost of Revenue

For the six months ended June 30, 2022 and six months ended June 30, 2021, the Company incurred $725,000 of cost of revenue and $0 cost of revenue, respectively.

Expenses

For the six months ended June 30, 2022 and June 30, 2021, we incurred operating expenses of $47,562 and $58,427, respectively. The decrease in operating expenses is mainly due to decrease in professional fees in June 2022 associated with audit and accounting fees.

Net Income (Loss)

For the six months ended June 30, 2022 and June 30, 2021, we incurred net income of $102,439 and a net loss of $58,427, respectively. The increase in net income (loss) during the six months ended is mainly due to the presence of sales activity and a gross profit of $150,002 during the six months ended June 30, 2022 versus no sales and gross profit occurring during the six months ended June 30, 2021.

Liquidity and capital resources

Currently, we are relying on sales of our products. Currently, we pay costs associated with running a business on a day to day basis.

As of June 30, 2022, we had cash on hand of $64,289 and current liabilities of $1,056,243. As of December 31, 2021, we had cash on hand of $52,279 and current liabilities of $402,674.

To the extent that our capital resources are insufficient to meet current or planned operating requirements, we will seek additional funds through equity or debt financing, collaborative or other arrangements with corporate partners, licensees or others, and from other sources, which may have the effect of diluting the holdings of existing shareholders. The Company has no current arrangements with respect to, or sources of, such additional financing and we do not anticipate that existing shareholders will provide any portion of our future financing requirements.

No assurance can be given that additional financing will be available when needed or that such financing will be available on terms acceptable to the Company. If adequate funds are not available, we may be required to delay or terminate expenditures for certain of its programs that it would otherwise seek to develop and commercialize. This would have a material adverse effect on the Company.

Off-balance sheet arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

This item is not applicable as we are currently considered a smaller reporting company.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our CEO and CFO have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this document. Based on the evaluation, they have concluded that our disclosure controls and procedures are not effective in timely alerting them to material information relating to us that is required to be included in our periodic SEC filings and ensuring that information required to be disclosed by us in the reports we file or submit under the Act is accumulated and communicated to our management, including our chief financial officer, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls and procedures were not effective as of June 30, 2022 due to the material weaknesses as disclosed in the Company’s Annual Report on Form 10-12G filed with the SEC.

Limitations of the Effectiveness of Disclosure Controls and Internal Controls

Our management, including our Principal Executive Officer and Principal Financial Officer, does not expect that our disclosure controls and internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control.

The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions; over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting subsequent to June 30, 2022, which were identified in connection with our management’s evaluation required by paragraph (d) of rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We know of no material, existing or pending legal proceedings against our Company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to our interest.

ITEM 1A. RISK FACTORS

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

THE EFFECTS OF THE RECENT COVID-19 CORONAVIRUS PANDEMIC ARE NOT IMMEDIATELY KNOWN, BUT MAY ADVERSELY AFFECT OUR BUSINESS, RESULTS OF OPERATIONS, FINANCIAL CONDITION, LIQUIDITY, AND CASH FLOW.

Presently, the impact of COVID-19 has not shown any imminent adverse effects on our business. This notwithstanding, it is still unknown and difficult to predict what adverse effects, if any, COVID-19 can have on our business, or against the various aspects of same, or how COVID-19 will continue to effect the world as the virus case numbers rise and fall.

As of the date of this Quarterly Report, COVID-19 coronavirus has been declared a pandemic by the World Health Organization, has been declared a National Emergency by the United States Government. COVID-19 coronavirus caused significant volatility in global markets. The spread of COVID-19 coronavirus has caused public health officials to recommend precautions to mitigate the spread of the virus, especially as to travel and congregating in large numbers. In addition, certain countries, states and municipalities have enacted, quarantining and “shelter-in-place” regulations which severely limit the ability of people to move and travel and require non-essential businesses and organizations to close. While some places have lessened their “shelter-in-place” restrictions and travel bans, as they are removed there is no certainty that an outbreak will not occur, and additional restrictions imposed again in response.

It is unclear how such restrictions, which will contribute to a general slowdown in the global economy, will affect our business, results of operations, financial condition and our future strategic plans. Shelter-in-place and essential-only travel regulations could negatively impact us. The current status of COVID-19 coronavirus closures and restrictions could negatively impact our ability to receive funding from our existing capital sources as each business is and has been affected uniquely.

If any of our employees, consultant, customers, or visitors were to become infected we could be forced to close our operations temporarily as a preventative measure to prevent the risk of spread which could also negatively impact our ability to receive funding from our existing capital sources as each business is and has been affected uniquely

In addition, our headquarters are located in Hong Kong, China which experienced restrictions on individuals and business shutdowns as the result of COVID-19. It is unclear at this time how these restrictions will be continued and/or amended as the pandemic evolves. We are hopeful that COVID-19 closures will have only a limited effect on our operations.

GENERAL SECURITIES MARKET UNCERTAINTIES RESULTING FROM THE COVID-19 PANDEMIC.

Since the outset of the pandemic the United States and worldwide national securities markets have undergone unprecedented stress due to the uncertainties of the pandemic and the resulting reactions and outcomes of government, business and the general population. These uncertainties have resulted in declines in all market sectors, increases in volumes due to flight to safety and governmental actions to support the markets. As a result, until the pandemic has stabilized, the markets may not be available to the Company for purposes of raising required capital. Should we not be able to obtain financing when required, in the amounts necessary to execute on our plans in full, or on terms which are economically feasible we may be unable to sustain the necessary capital to pursue our strategic plan and may have to reduce the planned future growth and/or scope of our operations.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None

ITEM 3. DEFAULTS UPON SENIOR SECURITES

None

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS

None

ITEM 5. OTHER INFORMATION

None

ITEM 6. EXHIBITS

The following exhibits are included as part of this report by reference:

Exhibit Number		Exhibit Description
31.1		Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2		Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1		Certification of the Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2		Certification of the Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Exhibit 101.INS *		XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
Exhibit 101.SCH *		Inline XBRL Taxonomy Extension Schema Document.
Exhibit 101.CAL *		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
Exhibit 101.LAB *		Inline XBRL Taxonomy Extension Label Linkbase Document.
Exhibit 101.PRE *		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
Exhibit 101.DEF *		Inline XBRL Taxonomy Extension Definition Linkbase Document.
Exhibit 104 *		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.